Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.85
-0.39 (-2.74%)
Aug 19, 2026, 2:14 PM EDT - Market open

Surgery Partners Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-88.6-77.9-168.1-11.9-54.6-70.9
Depreciation & Amortization
177.2176152.6118.1114.898.8
Loss (Gain) From Sale of Assets
33.730.440.614.411.12.2
Loss (Gain) on Equity Investments
0.4-0.8-2-2.2-1.80.2
Stock-Based Compensation
1014.833.317.718.417.4
Other Operating Activities
239.9242.2362.6221.2231.6220.7
Change in Accounts Receivable
-73.7-53.8-72.1-47.2-35.3-32.1
Change in Other Net Operating Assets
-40.9-56.6-46.8-16.3-125.4-149.2
Operating Cash Flow
258274.3300.1293.8158.887.1
Operating Cash Flow Growth
-2.24%-8.60%2.14%85.01%82.32%-64.72%
Capital Expenditures
-70.4-78.7-90.4-88.8-80.6-57.6
Sale of Property, Plant & Equipment
3.946.52.625.812.96
Cash Acquisitions
-118.2-162.1-378.8-80-146.4-285.8
Investment in Securities
-7.1-11.82.9-48.9-82.35.4
Other Investing Activities
-13.7-40.5-24.8-33.7-11.50.3
Investing Cash Flow
-205.5-246.6-488.5-225.6-307.9-331.7
Long-Term Debt Issued
-1,2031,730826.6217.8299.4
Long-Term Debt Repaid
--1,040-1,279-807.1-862-343.2
Net Debt Issued (Repaid)
119.8162.8450.419.5-644.2-43.8
Issuance of Common Stock
----882.9581.8
Preferred Dividends Paid
------5.1
Dividends Paid
------5.1
Other Financing Activities
-205.7-220.1-188.4-174.7-196.6-216.6
Financing Cash Flow
-85.9-57.3262-155.242.1316.3
Net Cash Flow
-33.4-29.673.6-87-10771.7
Free Cash Flow
187.6195.6209.720578.229.5
Free Cash Flow Growth
7.02%-6.72%2.29%162.15%165.08%-85.54%
Free Cash Flow Margin
5.57%5.91%6.73%7.47%3.08%1.33%
Free Cash Flow Per Share
1.461.541.661.630.850.41
Levered Free Cash Flow
183.56164.71192.28143.3817.2521.04
Unlevered Free Cash Flow
367.25335.09318.34264164.06159.16
Cash Income Tax Paid
1.21.21.61.41.81.5
Change in Working Capital
-114.6-110.4-118.9-63.5-160.7-181.3
SEC Filings: 10-K · 10-Q